Bioxodes Raises €12M in Series A Funding Round
Bioxodes, a Gosselies, Belgium-based biopharmaceutical company which specializes in the development of novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, raised €12M in Series A funding.